Shares of Indian pharmaceutical businesses, including Gland Pharma Ltd, Laurus Labs Ltd, Glenmark Pharmaceuticals Ltd, and Biocon Ltd, dropped as much as 8% on Monday,...
Shares of Glenmark Pharmaceuticals Ltd soared 3% on 3 March after the company announced acquiring and launching Acetylcysteine injection in the United States through its...
Shares of Glenmark Pharmaceuticals Ltd were trading in the red and 1% lower on Thursday, 27 February, despite the company’s US-based subsidiary announcing launching its...
Shares of Glenmark Pharmaceuticals Ltd were trading in the green and 2% higher on 21 January after the company’s subsidiary, Glenmark Pharmaceuticals Inc., USA, announced...
Shares of Glenmark Pharmaceuticals Ltd jumped more than 4% on 10 December following the company’s announcement that the initial clinical data for its blood cancer...
The shares of Glenmark Pharmaceuticals Ltd were trading in the green and 1% higher on 17 May after the company announced receiving final approval from the...
Gland Pharma Ltd. announced on Tuesday that the US health government has approved its generic Edaravone injection for the treatment of amyotrophic lateral sclerosis. According...
Shares of Glenmark Pharmaceuticals Ltd were trading in the green and 1% higher on 29 April after the company announced receiving USFDA final approval for...
Glenmark Pharmaceuticals Limited’s share price rose over 6% on Thursday after the company reported its quarterly earnings for October-December. For the third quarter of FY...
Shares of Glenmark Pharmaceuticals were trading in the green on 27 September after its subsidiary Glenmark Speciality SA signed an agreement with Cosmo Pharmaceuticals NV...